Samantha received her B.Sc. (Hons.) in Life Sciences at Queen’s University, specializing in Biomedical Sciences, with a focus on Drug Development and Human Toxicology. In her thesis project, she looked at the ability of the neutraceutical sulforaphane to upregulate DNA repair pathways through modifications in histone acetylation. Currently, Samantha is a Ph.D. student in Pharmaceutical Sciences at the University of Toronto and is also in the Collaborative Specialization in Biomedical Toxicology program. In her current research, she is investigating the mechanism of idiosyncratic drug-induced agranulocytosis and is working to characterize the early immune changes observed following treatment with the anti-schizophrenic medication clozapine. Samantha is a new member on the STC Board of Directors and is also serving as the Vice-Chair for the American Association of Pharmaceutical Scientists, University of Toronto Student Chapter for 2019-2020.
Ph.D. student, Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy
University of Toronto
144 College Street
Toronto, ON M5S3M2
Phone: (289) 259-3225